Published in Cardiovasc Res on October 13, 2005
Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail (2010) 2.40
Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling. J Physiol (2009) 1.19
Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev (2008) 1.18
Four genetic loci influencing electrocardiographic indices of left ventricular hypertrophy. Circ Cardiovasc Genet (2011) 0.99
Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model. PLoS One (2010) 0.87
Myostatin is elevated in congenital heart disease and after mechanical unloading. PLoS One (2011) 0.85
Myostatin and insulin-like growth factor I: potential therapeutic biomarkers for pompe disease. PLoS One (2013) 0.83
POTENTIAL NON-GROWTH USES OF rhIGF-I. Growth Genet Horm (2007) 0.78
Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study. J Transl Med (2015) 0.76
Insulin-like growth factors and their potential role in cardiac epigenetics. J Cell Mol Med (2016) 0.75
Relation between serum myokines and phase II cardiac rehabilitation. Medicine (Baltimore) (2017) 0.75
Association of serum myokines and aerobic exercise training in patients with spinal cord injury: an observational study. BMC Neurol (2016) 0.75
New Treatment Strategies for Alcohol-Induced Heart Damage. Int J Mol Sci (2016) 0.75
What can genetic studies of left ventricular mass tell us? Circ Cardiovasc Genet (2011) 0.75
Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87
Abnormal conduction and morphology in the atrioventricular node of mice with atrioventricular canal targeted deletion of Alk3/Bmpr1a receptor. Circulation (2007) 2.93
Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning. Circulation (2008) 2.09
Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol (2010) 1.82
Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure. Circ Heart Fail (2010) 1.57
Short communication: vascular smooth muscle cell stiffness as a mechanism for increased aortic stiffness with aging. Circ Res (2010) 1.56
Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. Circ Res (2005) 1.48
Mechanism of gender-specific differences in aortic stiffness with aging in nonhuman primates. Circulation (2007) 1.38
Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev Biol (2006) 1.35
Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology (2002) 1.33
Program of cell survival underlying human and experimental hibernating myocardium. Circ Res (2004) 1.27
Tempting fate: BMP signals for cardiac morphogenesis. Cytokine Growth Factor Rev (2003) 1.26
Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. Am J Physiol Heart Circ Physiol (2008) 1.23
Sex-specific regulation of gene expression in the aging monkey aorta. Physiol Genomics (2007) 1.23
H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart. Circ Res (2005) 1.19
Adenylyl cyclase type 5 protein expression during cardiac development and stress. Am J Physiol Heart Circ Physiol (2009) 1.16
Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy. Circulation (2003) 1.10
Quaking is essential for blood vessel development. Genesis (2002) 1.10
Proteasome inhibitors and cardiac cell growth. Cardiovasc Res (2009) 1.10
H11 kinase is a novel mediator of myocardial hypertrophy in vivo. Circ Res (2002) 1.09
H11 kinase/heat shock protein 22 deletion impairs both nuclear and mitochondrial functions of STAT3 and accelerates the transition into heart failure on cardiac overload. Circulation (2011) 1.09
Insights into cardioprotection obtained from study of cellular Ca2+ handling in myocardium of true hibernating mammals. Am J Physiol Heart Circ Physiol (2004) 1.03
Apoptosis predominates in nonmyocytes in heart failure. Am J Physiol Heart Circ Physiol (2009) 1.02
Activation of the bone morphogenetic protein receptor by H11kinase/Hsp22 promotes cardiac cell growth and survival. Circ Res (2009) 1.02
Protein turnover in cardiac cell growth and survival. Cardiovasc Res (2005) 1.00
H11 has dose-dependent and dual hypertrophic and proapoptotic functions in cardiac myocytes. Biochem J (2005) 0.99
Proteasome activation during cardiac hypertrophy by the chaperone H11 Kinase/Hsp22. Cardiovasc Res (2007) 0.96
The role of the ubiquitin-proteasome pathway in cardiovascular disease. Cardiovasc Res (2009) 0.92
Therapeutic potential of H11 kinase for the ischemic heart. Cardiovasc Drug Rev (2007) 0.92
Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction. Am J Physiol Cell Physiol (2009) 0.92
Characterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failure. J Biol Chem (2008) 0.90
Novel mechanisms mediating stunned myocardium. Heart Fail Rev (2003) 0.89
An autonomous BMP2 regulatory element in mesenchymal cells. J Cell Biochem (2011) 0.86
Characterization of pDJA1, a cardiac-specific chaperone found by genomic profiling of the post-ischemic swine heart. Cardiovasc Res (2003) 0.85
Preemptive conditioning of the swine heart by H11 kinase/Hsp22 provides cardiac protection through inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol (2011) 0.84
Design of a miniature tissue culture system to culture mouse heart valves. Ann Biomed Eng (2010) 0.83
Pre- and post-synaptic sympathetic function in human hibernating myocardium. Eur J Nucl Med Mol Imaging (2007) 0.83
Pre-emptive conditioning of the ischemic heart. Cardiovasc Hematol Agents Med Chem (2008) 0.81
Increased expression of H11 kinase stimulates glycogen synthesis in the heart. Mol Cell Biochem (2004) 0.80
Cardiac H11 kinase/Hsp22 stimulates oxidative phosphorylation and modulates mitochondrial reactive oxygen species production: Involvement of a nitric oxide-dependent mechanism. Free Radic Biol Med (2012) 0.79
The valosin-containing protein promotes cardiac survival through the inducible isoform of nitric oxide synthase. Cardiovasc Res (2013) 0.79
An in vivo map of bone morphogenetic protein 2 post-transcriptional repression in the heart. Genesis (2011) 0.79
Neurally-mediated increase in calcineurin activity regulates cardiac contractile function in absence of hypertrophy. Cardiovasc Res (2003) 0.76
NO with no NOS in ischemic heart. Cardiovasc Res (2007) 0.75
Ubiquitin, a novel paracrine messenger of cardiac cell survival. Cardiovasc Res (2010) 0.75
Sex differences in myocardial infarction and rupture. J Mol Cell Cardiol (2007) 0.75
Remodeling of the myocardium in early trabeculation and cardiac valve formation; a role for TGFβ2. Int J Dev Biol (2013) 0.75